61
Participants
Start Date
May 31, 1997
Primary Completion Date
June 30, 2000
Study Completion Date
June 30, 2000
Ganciclovir implant and oral ganciclovir
oral ganciclovir, 1 gm three times daily
Cidofovir intravenous
intravenous, 5 mg/kg once weekly for two doses, followed by 5 mg/kg every other week
Department of Ophthalmology, New York University Medical Center, New York
Department of Ophthalmology, New York Hospital-Cornell Medical Center, New York
The Emory Clinic, Emory University, Atlanta
Bascom Palmer Eye Institute, University of Miami, Miami
Department of Ophthalmology, Northwestern University, Chicago
LSU Eye Center, Louisiana State University Medical Center, New Orleans
Cullen Eye Institute, Baylor College of Medicine, Houston
LAC/USC Medical Center, 5P21 Rand Schrader Clinic, Los Angeles
Beckman Vision Center, University of California, San Francisco, San Francisco
Department of Ophthalmology, University of California, Irvine, Irvine
Shiley Eye Center Center, 0946, University of California, San Diego, La Jolla
Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles
University of South Florida, MDC Box 21, Tampa
Division of Infectious Diseases, Indiana University, Indianapolis, Indianapolis
The Wilmer Ophthalmological Institute, The Johns Hopkins University School of Medicine, Baltimore
Harvard/BCH AIDS Clinical Trials Unit, Massachusetts General Hospital, Boston
UMDNJ-New Jersey Medical School, Newark
Department of Ophthalmology, Mount Sinai School of Medicine, New York
University of North Carolina at Chapel Hill, Chapel Hill
Johns Hopkins Bloomberg School of Public Health
OTHER